GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | 8/10/2026 7:02:17 AM | View | Financials | Earnings | SEC | 2Q 2026 | Export Earnings Model | ||||
| Oruka Therapeutics, Inc. (ORKA) | 5/13/2026 4:16:19 PM | Small | View | Financials | 10-Q | SEC | 1Q 2026 ending: 3/31/2026 | Assets $504,480,000 | EPS -$0.48 | ||
| Oruka Therapeutics, Inc. (ORKA) | 5/13/2026 4:06:30 PM | View | Financials | Earnings | WIRE | 1Q 2026 | Assets $504,480,000 | EPS -$0.48 | Export Earnings Model | ||
| Oruka Therapeutics, Inc. (ORKA) | 4/30/2026 5:27:10 PM | View | Financials | Earnings (Prelim) | SEC | 1Q 2026 | Export Earnings Model | ||||
| Oruka Therapeutics, Inc. (ORKA) | 4/17/2026 4:11:14 PM | View | Proxy | SEC | Y 2025 | ||||||
| Oruka Therapeutics, Inc. (ORKA) | 3/12/2026 4:14:30 PM | Small | View | Financials | 10-K | SEC | Y 2025 ending: 12/31/2025 | Assets $488,617,000 | EPS -$1.85 | ||
| Oruka Therapeutics, Inc. (ORKA) | 3/12/2026 4:07:22 PM | View | Financials | Earnings | WIRE | Y 2025 | Assets $488,617,000 | EPS -$0.45 | Export Earnings Model | ||
| Oruka Therapeutics, Inc. (ORKA) | 11/12/2025 4:16:39 PM | Small | View | Financials | 10-Q | SEC | 3Q 2025 ending: 9/30/2025 | Assets $509,251,000 | EPS -$0.55 | ||
| Oruka Therapeutics, Inc. (ORKA) | 11/12/2025 4:08:39 PM | View | Financials | Earnings | WIRE | 3Q 2025 | Assets $509,251,000 | EPS -$0.55 | Export Earnings Model | ||
| Oruka Therapeutics, Inc. (ORKA) | 8/11/2025 4:14:30 PM | Small | View | Financials | 10-Q | SEC | 2Q 2025 ending: 6/30/2025 | Assets $357,418,000 | EPS -$0.46 | ||
| Oruka Therapeutics, Inc. (ORKA) | 8/11/2025 4:04:35 PM | View | Financials | Earnings | WIRE | 2Q 2025 | Assets $357,418,000 | EPS -$0.46 | Export Earnings Model | ||
| Oruka Therapeutics, Inc. (ORKA) | 5/14/2025 4:17:59 PM | View | Financials | Earnings | WIRE | 1Q 2025 | Assets $377,112,000 | EPS -$0.40 | Export Earnings Model | ||
| Oruka Therapeutics, Inc. (ORKA) | 5/14/2025 4:12:45 PM | Small | View | Financials | 10-Q | SEC | 1Q 2025 ending: 3/31/2025 | Assets $377,112,000 | EPS -$0.40 | ||
| Oruka Therapeutics, Inc. (ORKA) | 4/18/2025 3:01:32 PM | View | Proxy | SEC | Y 2024 | ||||||
| Oruka Therapeutics, Inc. (ORKA) | 3/6/2025 4:13:01 PM | Small | View | Financials | 10-K | SEC | Y 2024 ending: 12/31/2024 | Assets $396,019,000 | EPS -$3.87 | ||
| Oruka Therapeutics, Inc. (ORKA) | 3/6/2025 4:12:23 PM | View | Financials | Earnings | WIRE | Y 2024 | Assets $396,019,000 | EPS $2.21 | Export Earnings Model | ||
| Oruka Therapeutics, Inc. (ORKA) | 11/13/2024 4:27:48 PM | View | Financials | Earnings | WIRE | 3Q 2024 | Assets $414,090,000 | EPS -$1.46 | Export Earnings Model | ||
| Oruka Therapeutics, Inc. (ORKA) | 11/13/2024 4:10:43 PM | Small | View | Financials | 10-Q | SEC | 3Q 2024 ending: 9/30/2024 | Assets $414,090,000 | EPS -$1.46 | ||
| Oruka Therapeutics, Inc. (ORKA) | 10/18/2024 4:12:39 PM | View | Proxy | SEC | Y 2023 | ||||||
| Oruka Therapeutics, Inc. (ORKA) | 9/5/2024 5:19:20 PM | View | Financials | Earnings | SEC | 2Q 2024 | Assets $33,844,000 | EPS -$0.18 | Export Earnings Model | ||
| ARCA biopharma, Inc. (ORKA) | 8/1/2024 4:32:52 PM | View | Financials | Earnings | SEC | 2Q 2024 | Assets $33,844,000 | EPS -$0.18 | Export Earnings Model | ||
| ARCA biopharma, Inc. (ORKA) | 8/1/2024 4:17:29 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2024 ending: 6/30/2024 | Assets $33,844,000 | EPS -$0.18 | ||
| ARCA biopharma, Inc. (ORKA) | 4/25/2024 4:38:48 PM | View | Financials | Earnings | SEC | 1Q 2024 | Assets $36,706,000 | EPS -$0.14 | Export Earnings Model | ||
| ARCA biopharma, Inc. (ORKA) | 4/25/2024 4:26:57 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2024 ending: 3/31/2024 | Assets $36,706,000 | EPS -$0.14 | ||
| ARCA biopharma, Inc. (ORKA) | 2/1/2024 4:39:54 PM | View | Financials | Earnings | SEC | Y 2023 | Assets $37,861,000 | EPS -$0.08 | Export Earnings Model | ||
| ARCA biopharma, Inc. (ORKA) | 2/1/2024 4:29:54 PM | Micro | View | Financials | 10-K | SEC | Y 2023 ending: 12/31/2023 | Assets $37,861,000 | EPS -$0.37 | ||
| ARCA biopharma, Inc. (ORKA) | 12/19/2023 4:17:07 PM | View | Proxy | SEC | Y 2022 | ||||||
| ARCA biopharma, Inc. (ORKA) | 10/18/2023 4:35:59 PM | View | Financials | Earnings | SEC | 3Q 2023 | Assets $39,184,000 | EPS -$0.10 | Export Earnings Model | ||
| ARCA biopharma, Inc. (ORKA) | 10/18/2023 4:26:24 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2023 ending: 9/30/2023 | Assets $39,184,000 | EPS -$0.10 | ||
| ARCA biopharma, Inc. (ORKA) | 7/21/2023 4:36:55 PM | View | Financials | Earnings | SEC | 2Q 2023 | Assets $41,083,000 | EPS -$0.10 | Export Earnings Model | ||
| ARCA biopharma, Inc. (ORKA) | 7/21/2023 4:27:28 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2023 ending: 6/30/2023 | Assets $41,083,000 | EPS -$0.10 | ||
| ARCA biopharma, Inc. (ORKA) | 4/24/2023 4:37:21 PM | View | Financials | Earnings | SEC | 1Q 2023 | Assets $42,059,000 | EPS -$0.09 | Export Earnings Model | ||
| ARCA biopharma, Inc. (ORKA) | 4/24/2023 4:30:29 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2023 ending: 3/31/2023 | Assets $42,059,000 | EPS -$0.09 | ||
| ARCA biopharma, Inc. (ORKA) | 2/24/2023 4:40:44 PM | Micro | View | Financials | 10-K | SEC | Y 2022 ending: 12/31/2022 | Assets $43,085,000 | EPS -$0.69 | ||
| ARCA biopharma, Inc. (ORKA) | 2/24/2023 4:35:52 PM | View | Financials | Earnings | SEC | Y 2022 | Assets $43,085,000 | EPS -$0.08 | Export Earnings Model | ||
| ARCA biopharma, Inc. (ORKA) | 11/3/2022 4:41:10 PM | View | Proxy | SEC | Y 2021 | ||||||
| ARCA biopharma, Inc. (ORKA) | 10/28/2022 4:27:38 PM | View | Financials | Earnings | SEC | 3Q 2022 | Assets $44,965,000 | EPS -$0.16 | Export Earnings Model | ||
| ARCA biopharma, Inc. (ORKA) | 10/28/2022 4:21:27 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2022 ending: 9/30/2022 | Assets $44,965,000 | EPS -$0.16 | ||
| ARCA biopharma, Inc. (ORKA) | 8/2/2022 4:34:41 PM | View | Financials | Earnings | SEC | 2Q 2022 | Assets $48,101,000 | EPS -$0.22 | Export Earnings Model | ||
| ARCA biopharma, Inc. (ORKA) | 8/2/2022 4:16:33 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2022 ending: 6/30/2022 | Assets $48,101,000 | EPS -$0.22 | ||
| ARCA biopharma, Inc. (ORKA) | 5/2/2022 4:25:25 PM | View | Financials | Earnings | SEC | 1Q 2022 | Assets $51,014,000 | EPS -$0.23 | Export Earnings Model | ||
| ARCA biopharma, Inc. (ORKA) | 5/2/2022 4:19:38 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2022 ending: 3/31/2022 | Assets $51,014,000 | EPS -$0.23 | ||
| ARCA biopharma, Inc. (ORKA) | 3/14/2022 4:28:15 PM | View | Financials | Earnings | SEC | Y 2021 | Assets $54,924,000 | EPS -$0.40 | Export Earnings Model | ||
| ARCA biopharma, Inc. (ORKA) | 3/14/2022 4:16:04 PM | Micro | View | Financials | 10-K | SEC | Y 2021 ending: 12/31/2021 | Assets $54,924,000 | EPS -$1.39 | ||
| ARCA biopharma, Inc. (ORKA) | 11/2/2021 4:35:48 PM | View | Financials | Earnings | SEC | 3Q 2021 | Assets $60,192,000 | EPS -$0.33 | Export Earnings Model | ||
| ARCA biopharma, Inc. (ORKA) | 11/2/2021 4:14:02 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2021 ending: 9/30/2021 | Assets $60,192,000 | EPS -$0.33 | ||
| ARCA biopharma, Inc. (ORKA) | 8/4/2021 4:39:52 PM | View | Financials | Earnings | SEC | 2Q 2021 | Assets $65,338,000 | EPS -$0.34 | Export Earnings Model | ||
| ARCA biopharma, Inc. (ORKA) | 8/4/2021 4:13:05 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2021 ending: 6/30/2021 | Assets $65,338,000 | EPS -$0.34 | ||
| ARCA biopharma, Inc. (ORKA) | 5/11/2021 4:31:08 PM | View | Financials | Earnings | SEC | 1Q 2021 | Assets $69,183,000 | EPS -$0.33 | Export Earnings Model | ||
| ARCA biopharma, Inc. (ORKA) | 5/11/2021 4:13:50 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2021 ending: 3/31/2021 | Assets $69,183,000 | EPS -$0.33 | ||
| ARCA biopharma, Inc. (ORKA) | 4/21/2021 4:12:15 PM | View | Proxy | SEC | Y 2020 | ||||||
| ARCA biopharma, Inc. (ORKA) | 3/18/2021 4:41:43 PM | View | Financials | Earnings | SEC | Y 2020 | Assets $50,429,000 | EPS -$0.61 | Export Earnings Model | ||
| ARCA biopharma, Inc. (ORKA) | 3/18/2021 4:12:56 PM | Micro | View | Financials | 10-K | SEC | Y 2020 ending: 12/31/2020 | Assets $50,429,000 | EPS -$2.07 | ||
| ARCA biopharma, Inc. (ORKA) | 11/2/2020 4:24:59 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2020 ending: 9/30/2020 | Assets $51,982,000 | EPS -$0.33 | ||
| ARCA biopharma, Inc. (ORKA) | 11/2/2020 4:08:44 PM | View | Financials | Earnings | SEC | 3Q 2020 | Assets $51,982,000 | EPS -$0.33 | Export Earnings Model | ||
| ARCA biopharma, Inc. (ORKA) | 10/28/2020 4:23:34 PM | View | Proxy | SEC | Y 2019 | ||||||
| ARCA biopharma, Inc. (ORKA) | 8/5/2020 4:43:53 PM | View | Financials | Earnings | SEC | 2Q 2020 | Assets $11,633,000 | EPS -$0.73 | Export Earnings Model | ||
| ARCA biopharma, Inc. (ORKA) | 8/5/2020 4:19:52 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2020 ending: 6/30/2020 | Assets $11,633,000 | EPS -$0.73 | ||
| ARCA biopharma, Inc. (ORKA) | 5/6/2020 4:46:39 PM | View | Financials | Earnings | SEC | 1Q 2020 | Assets $7,461,000 | EPS -$0.83 | Export Earnings Model | ||
| ARCA biopharma, Inc. (ORKA) | 5/6/2020 4:25:27 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2020 ending: 3/31/2020 | Assets $7,461,000 | EPS -$0.83 | ||
| ARCA biopharma, Inc. (ORKA) | 2/18/2020 4:38:06 PM | View | Financials | Earnings | SEC | Y 2019 | Assets $8,536,000 | EPS -$0.69 | Export Earnings Model | ||
| ARCA biopharma, Inc. (ORKA) | 2/18/2020 4:26:24 PM | Micro | View | Financials | 10-K | SEC | Y 2019 ending: 12/31/2019 | Assets $8,536,000 | EPS -$4.15 | ||
| ARCA biopharma, Inc. (ORKA) | 11/6/2019 5:19:22 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2019 ending: 9/30/2019 | Assets $9,949,000 | EPS -$0.76 | ||
| ARCA biopharma, Inc. (ORKA) | 11/6/2019 4:13:56 PM | View | Earnings | WIRE | 3Q 2019 | Assets $9,949,000 | EPS -$0.76 | ||||
| ARCA biopharma, Inc. (ORKA) | 10/25/2019 5:04:59 PM | View | Proxy | SEC | Y 2018 | ||||||
| ARCA biopharma, Inc. (ORKA) | 8/1/2019 4:57:08 PM | View | Financials | Earnings | SEC | 2Q 2019 | Assets $10,388,000 | EPS -$1.14 | Export Earnings Model | ||
| ARCA biopharma, Inc. (ORKA) | 8/1/2019 4:55:40 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2019 ending: 6/30/2019 | Assets $10,388,000 | EPS -$1.14 | ||
| ARCA biopharma, Inc. (ORKA) | 5/8/2019 4:53:02 PM | View | Financials | Earnings | SEC | 1Q 2019 | Assets $8,606,000 | EPS -$1.86 | Export Earnings Model | ||
| ARCA biopharma, Inc. (ORKA) | 5/8/2019 4:32:11 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2019 ending: 3/31/2019 | Assets $8,606,000 | EPS -$1.86 | ||
| ARCA biopharma, Inc. (ORKA) | 2/27/2019 4:34:23 PM | View | Financials | Earnings | SEC | Y 2018 | Assets $6,825,000 | EPS -$1.92 | Export Earnings Model | ||
| ARCA biopharma, Inc. (ORKA) | 2/27/2019 4:31:56 PM | Micro | View | Financials | 10-K | SEC | Y 2018 ending: 12/31/2018 | Assets $6,825,000 | EPS -$10.31 | ||
| ARCA biopharma, Inc. (ORKA) | 11/14/2018 5:07:17 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2018 ending: 9/30/2018 | Assets $8,445,000 | EPS -$2.06 | ||
| ARCA biopharma, Inc. (ORKA) | 11/14/2018 5:03:00 PM | View | Financials | Earnings | SEC | 3Q 2018 | Assets $8,445,000 | EPS -$2.06 | Export Earnings Model | ||
| ARCA biopharma, Inc. (ORKA) | 9/20/2018 4:08:49 PM | View | Proxy | SEC | Y 2017 | ||||||
| ARCA biopharma, Inc. (ORKA) | 8/9/2018 4:56:19 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2018 ending: 6/30/2018 | Assets $10,067,000 | EPS -$2.74 | ||
| ARCA biopharma, Inc. (ORKA) | 8/9/2018 4:40:12 PM | View | Financials | Earnings | SEC | 2Q 2018 | Assets $10,067,000 | EPS -$2.74 | Export Earnings Model | ||
| ARCA biopharma, Inc. (ORKA) | 5/8/2018 4:54:26 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2018 ending: 3/31/2018 | Assets $12,788,000 | EPS -$3.61 | ||
| ARCA biopharma, Inc. (ORKA) | 5/8/2018 4:54:22 PM | View | Financials | Earnings | SEC | 1Q 2018 | Assets $12,788,000 | EPS -$3.61 | Export Earnings Model | ||
| ARCA biopharma, Inc. (ORKA) | 4/18/2018 12:02:18 PM | View | Proxy | SEC | Y 2017 | ||||||
| ARCA biopharma, Inc. (ORKA) | 3/22/2018 5:01:14 PM | View | Financials | Earnings | SEC | Y 2017 | Assets $12,365,000 | EPS -$0.34 | Export Earnings Model | ||
| ARCA biopharma, Inc. (ORKA) | 3/22/2018 4:40:25 PM | Micro | View | Financials | 10-K | SEC | Y 2017 ending: 12/31/2017 | Assets $12,365,000 | EPS -$1.77 | ||
| ARCA biopharma, Inc. (ORKA) | 2/26/2018 6:10:07 PM | View | Presentation | SEC | 1Q 2018 | ||||||
| ARCA biopharma, Inc. (ORKA) | 11/9/2017 4:42:54 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2017 ending: 9/30/2017 | Assets $16,921,000 | EPS -$0.39 | ||
| ARCA biopharma, Inc. (ORKA) | 11/9/2017 4:19:33 PM | View | Financials | Earnings | SEC | 3Q 2017 | Assets $16,921,000 | EPS -$0.39 | Export Earnings Model | ||
| ARCA biopharma, Inc. (ORKA) | 8/3/2017 4:46:17 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2017 ending: 6/30/2017 | Assets $17,296,000 | EPS -$0.59 | ||
| ARCA biopharma, Inc. (ORKA) | 8/3/2017 4:20:15 PM | View | Financials | Earnings | SEC | 2Q 2017 | Assets $17,296,000 | EPS -$0.59 | Export Earnings Model | ||
| ARCA biopharma, Inc. (ORKA) | 5/15/2017 4:23:35 PM | View | Financials | Earnings | SEC | 1Q 2017 | Assets $20,589,000 | EPS -$0.48 | Export Earnings Model | ||
| ARCA biopharma, Inc. (ORKA) | 5/15/2017 8:52:45 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2017 ending: 3/31/2017 | Assets $20,589,000 | EPS -$0.48 | ||
| ARCA biopharma, Inc. (ORKA) | 4/21/2017 11:00:34 AM | View | Proxy | SEC | Y 2016 | ||||||
| ARCA biopharma, Inc. (ORKA) | 3/21/2017 4:45:23 PM | View | Financials | Earnings | SEC | Y 2016 | Assets $24,629,000 | EPS -$0.46 | Export Earnings Model | ||
| ARCA biopharma, Inc. (ORKA) | 3/21/2017 4:08:07 PM | Micro | View | Financials | 10-K | SEC | Y 2016 ending: 12/31/2016 | Assets $24,629,000 | EPS -$1.81 | ||
| ARCA biopharma, Inc. (ORKA) | 11/14/2016 4:36:27 PM | View | Financials | Earnings | SEC | 3Q 2016 | Assets $28,679,000 | EPS -$0.51 | Export Earnings Model | ||
| ARCA biopharma, Inc. (ORKA) | 11/14/2016 4:31:04 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2016 ending: 9/30/2016 | Assets $28,679,000 | EPS -$0.51 | ||
| ARCA biopharma, Inc. (ORKA) | 8/9/2016 4:46:11 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2016 ending: 6/30/2016 | Assets $32,635,000 | EPS -$0.43 | ||
| ARCA biopharma, Inc. (ORKA) | 8/9/2016 4:35:19 PM | View | Financials | Earnings | SEC | 2Q 2016 | Assets $32,635,000 | EPS -$0.43 | Export Earnings Model | ||
| ARCA biopharma, Inc. (ORKA) | 5/11/2016 4:55:40 PM | View | Financials | Earnings | SEC | 1Q 2016 | Assets $36,928,000 | EPS -$0.40 | Export Earnings Model | ||
| ARCA biopharma, Inc. (ORKA) | 5/11/2016 4:47:13 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2016 ending: 3/31/2016 | Assets $36,928,000 | EPS -$0.40 | ||
| ARCA biopharma, Inc. (ORKA) | 4/27/2016 4:32:04 PM | View | Proxy | SEC | Y 2015 | ||||||
| ARCA biopharma, Inc. (ORKA) | 3/17/2016 4:43:30 PM | View | Financials | Earnings | SEC | Y 2015 | Assets $39,574,000 | EPS -$0.28 | Export Earnings Model | ||
| ARCA biopharma, Inc. (ORKA) | 3/17/2016 4:11:57 PM | Micro | View | Financials | 10-K | SEC | Y 2015 ending: 12/31/2015 | Assets $39,574,000 | EPS -$1.82 | ||
| ARCA biopharma, Inc. (ORKA) | 11/12/2015 4:51:39 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2015 ending: 9/30/2015 | Assets $42,397,000 | EPS -$0.31 | ||
| ARCA biopharma, Inc. (ORKA) | 11/12/2015 4:41:39 PM | View | Financials | Earnings | SEC | 3Q 2015 | Assets $42,397,000 | EPS -$0.31 | Export Earnings Model | ||
| ARCA biopharma, Inc. (ORKA) | 8/11/2015 4:33:10 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2015 ending: 6/30/2015 | Assets $45,115,000 | EPS -$0.69 | ||
| ARCA biopharma, Inc. (ORKA) | 8/11/2015 4:16:17 PM | View | Financials | Earnings | SEC | 2Q 2015 | Assets $45,115,000 | EPS -$0.69 | Export Earnings Model | ||
| ARCA biopharma, Inc. (ORKA) | 5/12/2015 4:39:37 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2015 ending: 3/31/2015 | Assets $13,261,000 | EPS -$0.91 | ||
| ARCA biopharma, Inc. (ORKA) | 4/14/2015 4:22:10 PM | View | Proxy | SEC | Y 2014 | ||||||
| ARCA biopharma, Inc. (ORKA) | 3/19/2015 4:53:30 PM | Micro | View | Financials | 10-K | SEC | Y 2014 ending: 12/31/2014 | Assets $16,132,000 | EPS -$3.31 | ||
| ARCA biopharma, Inc. (ORKA) | 11/12/2014 5:12:54 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2014 ending: 9/30/2014 | Assets $18,039,000 | EPS -$0.76 | ||
| ARCA biopharma, Inc. (ORKA) | 8/13/2014 5:22:34 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2014 ending: 6/30/2014 | Assets $20,540,000 | EPS -$0.11 | ||
| ARCA biopharma, Inc. (ORKA) | 5/13/2014 5:28:16 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2014 ending: 3/31/2014 | Assets $22,655,000 | EPS -$0.13 | ||
| ARCA biopharma, Inc. (ORKA) | 4/15/2014 5:00:34 PM | View | Proxy | SEC | Y 2013 | ||||||
| ARCA biopharma, Inc. (ORKA) | 3/20/2014 4:56:55 PM | Micro | View | Financials | 10-K | SEC | Y 2013 ending: 12/31/2013 | Assets $17,084,000 | EPS -$1.04 | ||
| ARCA biopharma, Inc. (ORKA) | 11/13/2013 4:39:18 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2013 ending: 9/30/2013 | Assets $19,138,000 | EPS -$0.16 | ||
| ARCA biopharma, Inc. (ORKA) | 8/13/2013 5:11:35 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2013 ending: 6/30/2013 | Assets $20,783,000 | EPS -$0.65 | ||
| ARCA biopharma, Inc. (ORKA) | 8/1/2013 2:55:54 PM | View | Proxy | SEC | Y 2012 | ||||||
| ARCA biopharma, Inc. (ORKA) | 5/13/2013 5:22:58 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2013 ending: 3/31/2013 | Assets $4,139,000 | EPS -$0.35 | ||
| ARCA biopharma, Inc. (ORKA) | 3/21/2013 5:20:23 PM | Micro | View | Financials | 10-K | SEC | Y 2012 ending: 12/31/2012 | Assets $3,212,000 | EPS -$1.94 | ||
| ARCA biopharma, Inc. (ORKA) | 2/1/2013 8:59:36 AM | View | Proxy | SEC | Y 2012 | ||||||
| ARCA biopharma, Inc. (ORKA) | 11/13/2012 5:18:05 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2012 ending: 9/30/2012 | Assets $3,462,000 | EPS -$0.41 | ||
| ARCA biopharma, Inc. (ORKA) | 8/13/2012 5:02:15 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2012 ending: 6/30/2012 | Assets $3,816,000 | EPS -$0.09 | ||
| ARCA biopharma, Inc. (ORKA) | 5/14/2012 4:51:40 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2012 ending: 3/31/2012 | Assets $4,958,000 | EPS -$0.69 | ||
| ARCA biopharma, Inc. (ORKA) | 4/5/2012 4:34:09 PM | View | Proxy | SEC | Y 2011 | ||||||
| ARCA biopharma, Inc. (ORKA) | 3/27/2012 4:32:58 PM | Micro | View | Financials | 10-K | SEC | Y 2011 ending: 12/31/2011 | Assets $6,502,000 | EPS -$3.21 | ||
| ARCA biopharma, Inc. (ORKA) | 11/14/2011 4:44:47 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2011 ending: 9/30/2011 | Assets $6,498,000 | EPS -$0.17 | ||
| ARCA biopharma, Inc. (ORKA) | 8/15/2011 5:15:22 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2011 ending: 6/30/2011 | Assets $8,581,000 | EPS $0.03 | ||
| ARCA biopharma, Inc. (ORKA) | 3/30/2011 5:09:15 PM | View | Proxy | SEC | Y 2010 | ||||||
| ARCA biopharma, Inc. (ORKA) | 4/7/2010 4:55:59 PM | View | Proxy | SEC | Y 2009 | ||||||
| ARCA biopharma, Inc. (ORKA) | 4/30/2009 4:49:02 PM | View | Proxy | SEC | Y 2008 |